Prevention of Relapse in Reflux Esophagitis: A Placebo Controlled Study of Ranitidine 150 mg BID and 300 mg BID

Autor: John H Hegarty, Lars Halvorsen, Bouke P Hazenberg, Andrzej Nowak, Colin L Smith, Alan B Thomson, G Vantrappen, Ceri J Mckenna, Jane G Mills

Publikováno v: Canadian Journal of Gastroenterology, Vol 11, Iss 1, Pp 83-88 (1997)

OBJECTIVE: To compare the efficacy and safety of long term use of ranitidine 150 mg bid, 300 mg bid and placebo in prevention of endoscopic and symptomatic relapse of reflux esophagitis in an international, double-blind, placebo controlled, parallel

Externí odkaz: https://doaj.org/article/d45145b5dd4a439780378a18780bac74

A new method for the measurement of bile acid turnover and pool size by a double label, single intubation technique

Autor: G Vantrappen, P Rutgeerts, Y Ghoos

Publikováno v: Journal of Lipid Research, Vol 22, Iss 3, Pp 528-531 (1981)

A new method is described for measuring the cholic acid turnover and pool size by a single duodenal intubation technique. The method is based on determination in a single bile sample of the ratio of the specific activities of [14C]cholic acid and [3H

Externí odkaz: https://doaj.org/article/edb75fbe527d4a5ea1507c1b07d9943e

The enterohepatic circulation of bile acids during continuous liquid formula perfusion of the duodenum.

Autor: P Rutgeerts, Y Ghoos, G Vantrappen

Publikováno v: Journal of Lipid Research, Vol 24, Iss 5, Pp 614-619 (1983)

The enterohepatic circulation of bile acids was studied in 16 normal volunteers and 8 cholecystectomy patients during continuous liquid formula perfusion of the duodenum. The fasting bile acid pool size in the 16 normals (5.534 +/- 1.472 mmol) exceed

Externí odkaz: https://doaj.org/article/dc75160ccd2c4f49b498cab4a8b869b4

Esophageal Motility Disorders

Autor: J. Hellemans, G. Vantrappen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2a9e99938182fb9e1eef3bc82e94b7bf
https://doi.org/10.1159/000400848

Phase III randomized study of two fluorouracil combinations with either interferon alfa-2a or leucovorin for advanced colorectal cancer. Corfu-A Study Group

Autor: A. Jorgensen, C. Cripps, R. Mayer Steinacker, Y. Merrouche, A. Man, G. Batist, J. Schuller, M. Wirth, S. Pyrhonen, G. Vantrappen, H. Bergermann, B. Weinerman, A. Jakobsen, A. Scaletzky, J. Seitz, Jean A. Maroun, H. Ravn, J. Bury, E. Francois, D. Lutz, R. Johansson, H. Smith, C. Blaes, F. Porzsolt, B. May, E. Pannuti, M. Budde, John A. Levi, Peter Sherman, J. Skillings, R. Goel, J. Heise, M. Froimtchuk, P. Guillou, M. De Lourdes Lopes De Oliveira, W. Kocha, P. Lankisch, P. Selby, K. Bertelsen, M Namer, John Stewart, Euan Walpole, R. Mertelsmann, J. Primrose, S. Holmstrom, P. Carey, J. Mejlholm, David R. Bell, Damien Thomson, U. Ward, G. Boos, Allan Solomon Zimet, V. Fosser, R. Luykx, T. Shore, G. Massimini, Stephen P. Ackland, Michael D. Green, E. Lindegaard Madsen, J. Salomon, M. Colleoni, A. K. L. Yap, John Zalcberg, G. Cartei, M. Schupp, E. E. Holdener, M. Giovannini, R. Egeli, C. Berg, P. Rebattu, Y. Becouarn, N. Brunsgaard, L. Cockey, C. Sodomann, L. Lepoutre, M. Reginster, M. Kjaer, E. Sandberg, J. Greving, L. De Facq, S. Somers, R. Brunet, O. P. Isokangas, E. Van Cutsem, C. Gadeberg, U. Fogl, E. Bajetta, P. Rougier, V. Kataja, D. Dalley

Publikováno v: Journal of Clinical Oncology. 13:921-928

PURPOSE To compare the efficacy and toxicity profiles of a combination of fluorouracil (5-FU) with recombinant human interferon alfa-2a (Roferon-A; Hoffman La-Roche AG, Basel, Switzerland) versus the combination of 5-FU with leucovorin (LV) in the tr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23d48f67e251086e9b5251c045bb93eb
https://doi.org/10.1200/jco.1995.13.4.921